Prevalence of celiac disease in multiple sclerosis

BMC Neurology

Volumn 11, Issue , 2011, Pages

  Rodrigo, Luis ^a   Hernández Lahoz, Carlos ^a   Fuentes, Dolores ^a   Alvarez, Noemí ^a   López Vázquez, Antonio ^a   González, Segundo ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DQ ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DERMATITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DUODENUM BIOPSY; FEMALE; GENETIC MARKER; HUMAN; HUMAN TISSUE; INTESTINE VILLUS ATROPHY; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PREVALENCE; PROSPECTIVE STUDY; RELATIVE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CELIAC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA-DQ ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; PREVALENCE; YOUNG ADULT;

EID: 79952347695     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-11-31     Document Type: Article

References (36)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1.502-17.
2. Chandran S, Hunt D, Joannides A, et al. Myelin repair: the role of stem and precursor cells in multiple sclerosis. Philos Trans R Soc London Biol Sci 2008, 363:171-83.
3. Sawcer S, Compston A. Multiple sclerosis: Light at the end of the tunnel. Eur J Hum Genet 2006, 14:257-8. 10.1038/sj.ejhg.5201561, 16391554.
4. Tsutsui S, Stys PK. Degeneration versus autoimmunity in Multiple Sclerosis. Ann Neurol 2009, 66:711-3. 10.1002/ana.21845, 20033985.
5. Lincoln JA, Cook SD. An overview of gene-epigenetic-environmental contributions to MS causation. J Neurol Sci 2009, 286:54-7. 10.1016/j.jns.2009.06.037, 19616791.
6. Tintore M, Rovira A, Río J, et al. New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology 2003, 60:27-30.
7. Carrol WM. Oral Therapy for Multiple Sclerosis. N Engl J Med 2010, 362:456-8. 10.1056/NEJMe0912019, 20089958.
8. James MB, Scott BB. Celiac disease: the cause of the various associated disorders?. Eur J Gastroenterol Hepatol 2001, 13:1119-21. 10.1097/00042737-200109000-00022, 11564967.
9. Rodrigo L. Celiac disease. World J Gastroenterol 2006, 12:6585-93.
10. Green PHR, Cellier C. Celiac disease. N Engl J Med 2007, 357:1731-43. 10.1056/NEJMra071600, 17960014.
11. Kakar S, Nehra V, Murray JA, et al. Significance of intraepithelial lymphocytosis in small biopsy samples with normal mucosal architecture. Am J Gastroenterol 2003, 98:2027-33. 10.1111/j.1572-0241.2003.07631.x, 14499783.
12. Shor DB, Barzilai O, Ram M, et al. Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth?. Ann N Y Acad Sci 2009, 1173:343-9. 10.1111/j.1749-6632.2009.04620.x, 19758171.
13. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "Mac Donald Criteria". Ann Neurol 2005, 58:840-6. 10.1002/ana.20703, 16283615.
14. Marine M, Fernández-Bañares F, Alsina M, et al. Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol 2009, 15:1331-8. 10.3748/wjg.15.1331, 2658830, 19294762.
15. Fernández E, Riestra S, Rodrigo L, et al. Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population. World J Gastroenterol 2005, 11:3762-6.
16. Marsh MN. Gluten, major histocompatibility complex and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992, 102:330-54.
17. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease. Time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999, 11:1185-94. 10.1097/00042737-199910000-00019, 10524652.
18. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol 2010, 9:318-30. 10.1016/S1474-4422(09)70290-X, 20170845.
19. Kom T. Pathophysiology of multiple sclerosis. J Neurol 2008, 255(Suppl 6):2-6.
20. López-Vázquez A, Rodrigo L, Fuentes D, et al. MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201. Gut 2002, 50:336-40. 1773124, 11839711.
21. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003, 163:286-92. 10.1001/archinte.163.3.286, 12578508.
22. Shan L, Molberg T, Parrot I, et al. Structural basis for gluten intolerance in celiac sprue. Science 2002, 297:2275-9. 10.1126/science.1074129, 12351792.
23. Molberg O, McAdam SN, Sollid LM. Role of tissue transglutaminase in celiac disease. J Pediatr Gastroenterol Nutr 2000, 30:232-40. 10.1097/00005176-200003000-00005, 10749404.
24. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet 2003, 362:30-7. 10.1016/S0140-6736(03)13803-2, 12853196.
25. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the auto-antigen of celiac disease. Nat Med 1997, 3:797-801. 10.1038/nm0797-797, 9212111.
26. Tursi A, Brandimarte G, Giorgetti GM. Prevalence of anti-tissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 2003, 36:219-21. 10.1097/00004836-200303000-00007, 12590232.
27. Esteve M, Rosinach M, Fernández-Bañares F, et al. Spectrum of gluten sensitive enteropathy in first-degree relatives of coeliac patients:clinical relevance of lymphocytic enteritis. Gut 2006, 55:1739-45. 10.1136/gut.2006.095299, 1856469, 16709658.
28. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000, 95:712-4. 10.1111/j.1572-0241.2000.01838.x, 10710062.
29. Santaolalla R, Fernández-Bañares F, Rodríguez R, et al. Diagnostic value of duodenal anti-tissue transglutaminase antibodies in gluten-sensitive enteropathy. Aliment Pharmacol Ther 2008, 27:820-9. 10.1111/j.1365-2036.2008.03652.x, 18284655.
30. Vivas S, Ruiz de Morales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009, 15:4775-80. 10.3748/wjg.15.4775, 2761554, 19824110.
31. Fernández-Bañares F, Esteve M, Salas A, et al. Systematic evaluation of causes of chronic watery diarrea with functional characteristics. Am J Gastroenterol 2007, 102(11):2520-2528.
32. Roche Herrero MC, Arcas Martínez J, Martínez-Bermejo A, et al. The prevalence of headache in a population of patients with coeliac disease. Rev Neurol 2001, 32:301-9.
33. Zelnik N, Pacht T, Obeid R, et al. Range of neurologic disorders in patients wih celiac disease. Pediatrics 2004, 113:1672-6. 10.1542/peds.113.6.1672, 15173490.
34. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology 2005, 128:S92-7. 10.1053/j.gastro.2005.02.018, 15825133.
35. Wong D, Dwinnel M, Schulzer M, et al. Ataxia and the role of antigliadin antibodies. Can J Neurol Sci 2007, 34:193-6.
36. Hadjivassiliou M, Aeschlimann P, Strigun A, et al. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 2008, 64:332-43. 10.1002/ana.21450, 18825674.